Analyst Price Targets — IART
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 15, 2025 12:34 pm | — | Truist Financial | $15.00 | $14.76 | TheFly | Integra LifeSciences price target raised to $15 from $13 at Truist |
| October 7, 2024 5:33 am | Ryan Zimmerman | BTIG | $20.00 | $17.43 | StreetInsider | BTIG Upgrades Integra LifeSciences (IART) to Neutral |
| July 30, 2024 8:59 am | Richard Newitter | Truist Financial | $26.00 | $24.59 | TheFly | Integra LifeSciences price target lowered to $26 from $32 at Truist |
| July 30, 2024 3:24 am | Joanne Wuensch | Citigroup | $23.00 | $25.42 | StreetInsider | Citi Downgrades Integra LifeSciences (IART) to Sell |
| July 29, 2024 4:12 pm | Ryan Zimmerman | BTIG | $22.00 | $25.42 | TheFly | Integra LifeSciences downgraded to Sell from Neutral at BTIG |
| July 16, 2024 7:33 am | Richard Newitter | Truist Financial | $32.00 | $29.84 | TheFly | Integra LifeSciences price target raised to $32 from $25 at Truist |
| May 7, 2024 7:16 am | Richard Newitter | Truist Financial | $25.00 | $23.14 | StreetInsider | Integra LifeSciences (IART) PT Lowered to $25 at Truist Securities |
| May 7, 2024 6:56 am | David Turkaly | JMP Securities | $40.00 | $23.14 | TheFly | Integra LifeSciences price target lowered to $40 from $49 at JMP Securities |
| May 6, 2024 4:15 pm | Vik Chopra | Wells Fargo | $25.00 | $23.14 | StreetInsider | Wells Fargo Downgrades Integra LifeSciences (IART) to Equal Weight |
| October 26, 2022 1:47 pm | Matt O'Brien | Piper Sandler | $50.00 | $46.85 | TheFly | Piper Sandler keeps Neutral on Integra after results, favors Conmed and Tandem |
Latest News for IART
IART tops Q4 EPS and revenue estimates despite margin pressure and a sales dip, as shares edge higher and 2026 guidance signals modest growth.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Integra LifeSciences (IART) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.97 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.